Product Information
- N-[4-[(2-amino-6-methylpyrimidin-4-yl)amino]phenyl]-4-(quinolin-4-ylamino)benzamide
Applications SGI-1027 is a quinoline derivative and a potent inhibitor of DNA methyltransferase (DNMT). SGI-1027 can be used as a potential therapeutic agent for the treatment of cancer and other diseases and also as a research tool to investigate the role of DNMTs in epigenetic events.
References Rilova, E., et al.: Chem. Med. Chem., 9, 590 (2014); Yoo, J., et al.: PLoS One, 8, e62152 (2013); Medina-Franco, J.L., et al.: Mol. Divers., 17, 337 (2013); Yoo, J., et al.: Curr. Comput-aid. Drug, 8, 317 (2012)
Chemical properties
Technical inquiry about: TR-S282375 SGI-1027
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.